Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Biogen Japan COO Ajai Sulekh Named as New President
November 1, 2018
- Daiichi Sankyo to Discontinue Development of Intradermal Flu Vaccine
November 1, 2018
- Astellas Sales Up 1.1% Driven by Xtandi, OAB Drugs, despite Slump in Japan Business
November 1, 2018
- Sanofi, Daiichi Sankyo to Terminate Marketing Partnership for Hib Vaccine in Japan; Sanofi to Take Over Sales from Jan.
November 1, 2018
- Sumitomo Dainippon Operating Profit Plummets 50% on Drug Price Cut, Generic Erosions
October 31, 2018
- Mitsubishi Tanabe Sales Slip 1.7% as Radicava Boon Fails to Counter Japan Drop
October 31, 2018
- Mitsubishi Tanabe Paints Murky Outlook for US Sales Target on Parkinson’s Development Delay
October 31, 2018
- Nesp Biosame to Hit Japan Market in July-September 2019
October 31, 2018
- Otsuka Pharmaceutical Factory to Jointly Develop Regenerative Medicine Products with Startup
October 31, 2018
- Shionogi’s Half-Year Profits Renew Records, but Crestor Generics Weigh on Topline
October 30, 2018
- Shionogi Chief Confident about 70% Market Share for Xofluza in Japan
October 30, 2018
- Europe OKs Xtandi for All CRPC Cases
October 30, 2018
- JCR Initiates Development of Temcell for Epidermolysis Bullosa
October 30, 2018
- Takeda Mulls Sale of Shire GI Pipeline to Clinch European Clearance
October 29, 2018
- Fujifilm Signs MOU on Clinical Development of Favipiravir in China with 3 Chinese Partners
October 29, 2018
- Taiho’s Lonsurf Grabs US Priority Review Status for Gastric Cancer
October 29, 2018
- Daiichi Sankyo, Merck KGaA, Pfizer to Collaborate for PI of DS-8201, Bavencio, and DDR Combo
October 29, 2018
- Lemborexant Improves Nighttime Activity in AD Patients with Irregular Sleep-Wake Rhythm Disorder in PII: Eisai
October 29, 2018
- Eisai, Biogen Tout BAN2401’s Clinical Effect Regardless of APOE4 Mutation
October 29, 2018
- Shionogi, Osaka Univ. to Collaborate on Medical Data Science for Effective Use of Real-World Data
October 26, 2018
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…